idebenone

Known as: hydroxydecyl ubiquinone, noben 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2018
0102019842018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
We have studied the effects of idebenone on mitochondrial function in cybrids derived from one normal donor (HQB17) and one… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Major advances in understanding the pathogenesis of inherited metabolic disease caused by mitochondrial DNA mutations have yet to… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2011
2011
Valerio Carelli, MD, PhD, Chiara La Morgia, MD, Maria Lucia Valentino, MD, Giovanni Rizzo, MD, PhD, Michele Carbonelli, MD, Anna… (More)
  • table 1
Is this relevant?
2003
2003
The authors report 1-year prospective data on eight patients with Friedreich ataxia. Idebenone did not halt the progression of… (More)
Is this relevant?
2003
2003
OBJECTIVE To determine the effect of idebenone on the rate of decline in Alzheimer's disease (AD). METHODS A 1-year… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Friedreich's ataxia encodes a protein of unknown function, frataxin. The loss of frataxin is caused by a large GAA… (More)
  • table 1
  • figure 1
Is this relevant?
2002
2002
BACKGROUND Antioxidant therapy has been applied to Friedreich's ataxia patients. We assessed the effect of idebenone treatment in… (More)
Is this relevant?
2001
2001
Friedreich ataxia (FA), the most common form of degenerative ataxia, is thought to be caused by respiratory deficiency due to… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND Friedreich's ataxia is caused by a deficiency of frataxin, a protein involved in regulation of mitochondrial iron… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Amyloid beta-peptide (A beta), the major constituent of the senile plaques in the brains of patients with Alzheimer's disease, is… (More)
Is this relevant?